BEYONTTRA Trademark

Trademark Overview

On Monday, February 28, 2022, a trademark application was filed for BEYONTTRA with the United States Patent and Trademark Office. The USPTO has given the BEYONTTRA trademark a serial number of 97288149. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Sunday, February 23, 2025. This trademark is owned by BridgeBio Pharma, Inc.. The BEYONTTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
beyonttra

General Information

Serial Number97288149
Word MarkBEYONTTRA
Filing DateMonday, February 28, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateSunday, February 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBridgeBio Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304
Party NameBridgeBio Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events

Event DateEvent Description
Thursday, March 3, 2022NEW APPLICATION ENTERED
Thursday, March 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 11, 2022ASSIGNED TO EXAMINER
Tuesday, December 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 8, 2024SOU EXTENSION 2 GRANTED
Friday, August 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 11, 2023SOU EXTENSION 1 FILED
Friday, August 11, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2024SOU EXTENSION 2 FILED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 28, 2024SOU TEAS EXTENSION RECEIVED
Sunday, July 28, 2024SOU EXTENSION 3 FILED
Sunday, February 23, 2025SOU TEAS EXTENSION RECEIVED
Sunday, February 23, 2025SOU EXTENSION 4 FILED
Sunday, February 23, 2025SOU EXTENSION 4 GRANTED
Monday, February 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 28, 2024SOU EXTENSION 3 GRANTED

Related Keywords

beyonttra orthopedic metabolic diseases disorders genetic neurological treatment oncological cardiological dermatological